These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23361282)

  • 1. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
    Gupta S; Sodhani P; Jain S
    J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
    Dermawan JKT; Policarpio-Nicolas ML
    Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
    Lew M; Cantley R; Heider A; Jing X
    Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
    Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
    Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
    Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
    Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
    Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
    Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
    Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
    Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying the primary site of malignancy in carcinomatous serous effusions using immunocytochemistry.
    Kundu R; Parwaiz A; Gupta P; Rohilla M; Gupta N; Srinivasan R; Dey P
    Cytopathology; 2022 Nov; 33(6):678-687. PubMed ID: 35749049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bull's eye (target) inclusions in neoplastic cells in malignant serous effusions. A study of 289 cases.
    Kumar PV; Eqbali S; Monabati A; Talei AR
    Acta Cytol; 2000; 44(4):543-6. PubMed ID: 10934946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
    Sundling KE; Cibas ES
    Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions.
    Ascoli V; Taccogna S; Scalzo CC; Nardi F
    Diagn Cytopathol; 1995 Jun; 12(4):303-8. PubMed ID: 7656755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult granulosa cell tumor presenting as metastases to the pleural and peritoneal cavity.
    Gupta N; Rajwanshi A; Dey P; Suri V
    Diagn Cytopathol; 2012 Oct; 40(10):912-5. PubMed ID: 21618710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of the EZH2 Immunomarker in Malignant Effusion Cytology.
    Ang PP; Tan GC; Karim N; Wong YP
    Acta Cytol; 2020; 64(3):248-255. PubMed ID: 31352449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology.
    Sahu S; Gupta P; Susheilia S; Gautam U; Dey P
    Cytopathology; 2021 Mar; 32(2):169-179. PubMed ID: 33040400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.